Dyslipidemia and reduced retinal layer thicknesses in mild to moderate non-proliferative diabetic retinopathy

轻度至中度非增殖性糖尿病视网膜病变中的血脂异常和视网膜层厚度减少

阅读:1

Abstract

OBJECTIVE: To investigate the changes in ganglion cell layer-inner plexiform layer (GCL-IPL) thickness and its association with peripheral blood indices in non-proliferative diabetic retinopathy (NPDR). METHODS: In this cross-sectional study, 132 participants were categorized into three groups: 30 healthy volunteers (control group), 50 diabetic patients with non-diabetic retinopathy (NDR group), and 52 patients with NPDR. Optical coherence tomography (OCT) was used to measure the retinal nerve fiber layer (RNFL) and GCL-IPL thicknesses in the macula. The associations between RNFL loss and systemic risk factors for DR, such as diabetes duration, triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and hemoglobin A1c (HbA1c) were evaluated. RESULTS: The average, superior, and nasal thicknesses in the NDR and NPDR groups were significantly thinner compared to the control group (P=0.002, 0.020, 0.090, respectively). Similarly, GCL-IPL thicknesses in the 3 mm and 6 mm zones of the NDR and NPDR groups were thinner than those in the control group (P=0.040, 0.022, 0.037, respectively). Temporal thicknesses in the 3 mm range of the NDR and NPDR groups were also thinner than in the control group (P=0.010). Superior RNFL thickness was positively correlated with HbA1c (r=0.200, P=0.044), and negatively correlated with HDL (r=-0.198, P=0.047). The average inferior and nasal GCL-IPL thicknesses were negatively correlated with TC across the 3 mm zone (r=-0.211, P=0.033; r=-0.224, P=0.023; r=-0.227, P=0.022). Additionally, the average thickness of GCL-IPL in the 6-mm range were positively correlated with the duration of diabetes (r=0.196, P=0.048). CONCLUSION: This study demonstrates that dyslipidemia in diabetic patients correlates with reductions in RNFL and GCL-IPL thicknesses, suggesting a role in the pathogenesis of diabetic retinopathy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。